Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-08

FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a generic fixed-dose combination of irbesartan and hydrochlorothiazide from Hikma Pharmaceuticals USA Inc. through an Original Application (ANDA) f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)